Biomonitoring of perfluoroalkyl acids in human urine and estimates of biological half-life

Environ Sci Technol. 2013 Sep 17;47(18):10619-27. doi: 10.1021/es401905e. Epub 2013 Aug 27.

Abstract

Perfluoroalkyl acids (PFAAs) are persistent and bioaccumulative compounds that have been associated with adverse health outcomes. In human blood, PFAAs exist as both linear and branched isomers, yet for most linear homologues, and for all branched isomers, elimination rates are unknown. Paired blood and urine samples (n = 86) were collected from adults in China. They were analyzed by a sensitive isomer-specific method that permitted the detection of many PFAAs in human urine for the first time. For all PFAAs except perfluoroundecanoate (PFUnA), levels in urine correlated positively with levels in blood. Perfluoroalkyl carboxylates (PFCAs) were excreted more efficiently than perfluoroalkane sulfonates (PFSAs) of the same carbon chain-length. In general, shorter PFCAs were excreted more efficiently than longer ones, but for PFSAs, perfluorooctanesulfonate (PFOS, a C8 compound) was excreted more efficiently than perfluorohexanesulfonate (PFHxS, a C6 compound). Among PFOS and perfluorooctanoate (PFOA) isomers, major branched isomers were more efficiently excreted than the corresponding linear isomer. A one-compartment model was used to estimate the biological elimination half-lives of PFAAs. Among all PFAAs, the estimated arithmetic mean elimination half-lives ranged from 0.5 ± 0.1 years (for one branched PFOA isomer, 5m-PFOA) to 90 ± 11 years (for one branched PFOS isomer, 1m-PFOS). Urinary excretion was the major elimination route for short PFCAs (C ≤ 8), but for longer PFCAs, PFOS and PFHxS, other routes of excretion likely contribute to overall elimination. Urinary concentrations are good biomarkers of the internal dose, and this less invasive strategy can therefore be used in future epidemiological and biomonitoring studies. The very long half-lives of long-chain PFCAs, PFHxS, and PFOS isomers in humans stress the importance of global and domestic exposure mitigation strategies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Caprylates / blood
  • Caprylates / urine*
  • China
  • Environmental Monitoring
  • Environmental Pollutants / blood
  • Environmental Pollutants / urine*
  • Fatty Acids / blood
  • Fatty Acids / urine*
  • Female
  • Fluorocarbons / blood
  • Fluorocarbons / urine*
  • Half-Life
  • Humans
  • Male
  • Middle Aged
  • Serum / chemistry

Substances

  • Caprylates
  • Environmental Pollutants
  • Fatty Acids
  • Fluorocarbons